In our previous study, some patients with newly diagnosed type 2 diabetes mellitus can maintain euglycaemia without hypoglycemic agents after 2-week intensive insulin therapies for long time. But the others didn’t respond well to the treatment. To identify patients who would get long-remission from this treatment, a retrospective study was conducted to compared the characters between them. An observation of 160 patients with newly dignosed T2DM (103 male, aged 50±10 ys,HbA1C 11±2.1%) after2-week therapy was studied remission rate. After the termination of short-term CSII, 65.6% patients maintained long-remission more than 1-year, 18.1%patients got short-remission less than 1-year, and 16.3% patients didn’t get remission from the therapy. Age, BMI and glucose metabolism at baseline were not significantly different among three groups. As the table below showed, the long-remission patients have statistically lower FPG, PPG, A1c and better HOMA-B just after therapy.

In conclusion, the beta cell function (which test by HOMA-B) might affect the remission rate mainly by the better improved metabolism of glucose.

 non-remission group at baseline non-remission group after therapy short-remission group at baseline short-remission group after therapy long-remission group at baseline long-remission group after therapy 
BMI 24.24 ±3.00 24.29 ±3.00 24.99 ±4.00 24.68 ±3.00 25.59 ±3.00 25.27 ±3.00 
FPG 12.94 ±3.00 7.79 ±1.50 12.13 ±3.00 6.34 ±1.20 11.45 ±3.00 6.08 ±1.30 
PPG 19.10 ±6.00 10.87 ±3.00 17.84 ±5.00  8.38 ±2.00  17.86 ±6.00  7.73 ±2.00  
GHbA1C 11.69 ±2.00 10.09 ±1.00 11.23 ±2.00 9.70 ±2.00  10.73 ±2.00 9.16 ±2.00  
HOMA-B 15.27 ±8.00 38.49 ±19.00  21.45 ±16.00 67.61 
 non-remission group at baseline non-remission group after therapy short-remission group at baseline short-remission group after therapy long-remission group at baseline long-remission group after therapy 
BMI 24.24 ±3.00 24.29 ±3.00 24.99 ±4.00 24.68 ±3.00 25.59 ±3.00 25.27 ±3.00 
FPG 12.94 ±3.00 7.79 ±1.50 12.13 ±3.00 6.34 ±1.20 11.45 ±3.00 6.08 ±1.30 
PPG 19.10 ±6.00 10.87 ±3.00 17.84 ±5.00  8.38 ±2.00  17.86 ±6.00  7.73 ±2.00  
GHbA1C 11.69 ±2.00 10.09 ±1.00 11.23 ±2.00 9.70 ±2.00  10.73 ±2.00 9.16 ±2.00  
HOMA-B 15.27 ±8.00 38.49 ±19.00  21.45 ±16.00 67.61 

Disclosure

X. Wan: None. J. Liu: None. Z. Huang: None. L. Liu: None. Y. Li: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.